Adamis Pharmaceuticals Corporation:企業のM&A・事業提携・投資動向

◆英語タイトル:Adamis Pharmaceuticals Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2034
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:62
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Adamis Pharmaceuticals Corporation – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Adamis Pharmaceuticals Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Adamis Pharmaceuticals Corporation since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Adamis Pharmaceuticals Corporation’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Adamis Pharmaceuticals Corporation. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Adamis Pharmaceuticals Corporation’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Adamis Pharmaceuticals Corporation and its subsidiaries since 2007.
- Information about key financial and legal advisors for Adamis Pharmaceuticals Corporation’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Adamis Pharmaceuticals Corporation’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
PARTNERSHIP 17
Partnership – Overview 17
Partnership – Deal reports 18
CAPITAL RAISING 29
Capital Raising – Overview 29
Capital Raising – Deal reports 30
APPENDIX 52
Contact Us 52
About MarketLine Financial Deals Database 52
Deal Definition and Methodology 54
About MarketLine 61

List of Tables
Table 1: Adamis Pharmaceuticals Corporation M&A volume and value trend (2014-YTD2018)
Table 2: Adamis Pharmaceuticals Corporation M&A activity by geography (2014-YTD2018)
Table 3: Adamis Pharmaceuticals Corporation partnership volume and value trend (2014-YTD2018)
Table 4: Adamis Pharmaceuticals Corporation partnership trend by key deal type (2014-YTD2018)
Table 5: Adamis Pharmaceuticals Corporation capital raising volume and value trend (2014-YTD2018)
Table 6: Adamis Pharmaceuticals Corporation capital raising by deal type (2014-YTD2018)

List of Figures
Figure 1: Adamis Pharmaceuticals Corporation M&A volume and value trend (2014-YTD2018)
Figure 2: Adamis Pharmaceuticals Corporation M&A activity by geography (2014-YTD2018)
Figure 3: Adamis Pharmaceuticals Corporation partnership volume and value trend (2014-YTD2018)
Figure 4: Adamis Pharmaceuticals Corporation partnership trend by key deal type (2014-YTD2018)
Figure 5: Adamis Pharmaceuticals Corporation capital raising volume and value trend (2014-YTD2018)
Figure 6: Adamis Pharmaceuticals Corporation capital raising by deal type (2014-YTD2018)

★海外企業調査レポート[Adamis Pharmaceuticals Corporation:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bioversys AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Bioversys AG (Bioversys) is a biotechnology company that researches and develops small molecules which turn off drug resistance against existing antibiotics. The company employs proprietary transcriptional regulator inhibitory compounds (TRIC) technology for screening, identifying and develo …
  • T&D Holdings, Inc.:企業の戦略・SWOT・財務情報
    T&D Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary T&D Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Lukoil Oil Co (LKOH):企業の財務・戦略的SWOT分析
    Lukoil Oil Co (LKOH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Varta Microbattery GmbH:企業の戦略的SWOT分析
    Varta Microbattery GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Lensar Inc:医療機器:M&Aディール及び事業提携情報
    Summary Lensar Inc (Lensar), a subsidiary of Alphaeon Corp is a medical device company that designs, develops and manufactures laser and advanced 3D imaging technology and devices for refractive cataract surgery. The company provides surgeon with superior femtosecond laser technology. It offers vari …
  • Amplifon SpA (AMP):医療機器:M&Aディール及び事業提携情報
    Summary Amplifon SpA (Amplifon) is a medical device company, which provides customized hearing solutions and services. It distributes hearing aids and other audio and telephony solutions. The company also offers related services such as audiological assessment, education, counseling, customization a …
  • iVascular SLU:企業の製品パイプライン分析2018
    Summary iVascular SLU (iVascular) is a designer and developer of advanced medical devices and implants for the treatment of cardiovascular system disorders. The company offers products in the fields of interventional cardiology, endovascular intervention and interventional neuroradiology including d …
  • Virgin Active Limited
    Virgin Active Limited - Strategy, SWOT and Corporate Finance Report Summary Virgin Active Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Omniox Inc-製薬・医療分野:企業M&A・提携分析
    Summary Omniox Inc (Omniox) is a biotechnology company that develops new medicines for hypoxic diseases. The company's H-NOX products are tailored for the treatment of hypoxic cancers, which include giloblastoma, metastatic brain cancer, head-and-neck cancer, pancreatic cancer, lung cancer, and pros …
  • Mainstream Renewable Power Ltd:企業の戦略的SWOT分析
    Mainstream Renewable Power Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • First Solar Inc (FSLR):企業の財務・戦略的SWOT分析
    First Solar Inc (FSLR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • North China Pharmaceutical Group Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary North China Pharmaceutical Group Corp (NCPC) is a healthcare products provider that manufactures and distributes formulation products, nutrition and health products, raw materials, and veterinary drugs. The company offers sirolimus capsules, clindamycin phosphate injection, mezlocillin sodiu …
  • East Energy Resources Limited:企業の戦略・SWOT・財務情報
    East Energy Resources Limited - Strategy, SWOT and Corporate Finance Report Summary East Energy Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Companhia de Transmissao de Energia Eletrica Paulista (TRPL4):企業の財務・戦略的SWOT分析
    Summary Companhia de Transmissao de Energia Eletrica Paulista (CTEEP) a subsidiary of Interconexion Electrica SA ESP, is an electric utility service provider that produces and distributes electricity. The utility owns and operates power generation plants and transmission lines and supplies electrici …
  • PNM Resources, Inc.:企業の戦略・SWOT・財務分析
    PNM Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary PNM Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • EVN AG (EVN):企業の財務・戦略的SWOT分析
    EVN AG (EVN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Elia System Operator SA (ELI):電力:M&Aディール及び事業提携情報
    Summary Elia System Operator SA (Elia) is a transmission system operator. It owns and operates high-voltage electricity transmission systems in Belgium and Germany. The company transmits electricity from generators to distribution system operators and industrial consumers. Elia also imports and expo …
  • Hydro-Electric Corporation:企業の戦略的SWOT分析
    Hydro-Electric Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Inpex Corp (1605):企業の財務・戦略的SWOT分析
    Inpex Corp (1605) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Cevec Pharmaceuticals GmbH:企業のM&A・事業提携・投資動向
    Cevec Pharmaceuticals GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cevec Pharmaceuticals GmbH Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆